drugset / Trial / NCT04435912
Hydrocortisone Per-treatment Decrease Side Effects of Protamine Sulfate
RandomizedParallel-groupDouble-blindPrevention
Summary
This study aims to compare the hemodynamic parameters within and between patients who received Protamine Sulfate (PS) with Hydrocortisone (HC) vs. Protamine Sulfate alone during cardiac surgeries.
Timeline
- Start
- 2019-07-04
- Primary completion
- 2020-04-30
- Completion
- 2020-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 200 mg | Intravenous |
Indications
No indication recorded.